Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/118640
Title: | ApoA-I Mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer. |
Author: | Cedó Giné, Lídia García León, Annabel Baila Rueda, Lucía Santos, David Grijalva, Victor Martínez Cignoni, Melanie Raquel Carbó, José M. Metso, Jari López Vilaró, Laura Zorzano Olarte, Antonio Valledor Fernández, Annabel Cenarro, Ana Jauhiainen, Matti Lerma, Enrique Fogelman, Alan M. Reddy, Srinivasa T. Escolà Gil, Joan Carles Blanco-Vaca, Francisco |
Keywords: | Càncer de mama Hiperlipoproteïnes Ratolins transgènics Pèptids Breast cancer High density lipoproteins Transgenic mice Peptides |
Issue Date: | 3-Nov-2016 |
Publisher: | Nature Publishing Group |
Abstract: | Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. We aimed to determine the effects of human apoA-I overexpression and administration of specific apoA-I mimetic peptide (D-4F) on tumour progression by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited breast cancer. Expression of human apoA-I in the mice did not affect tumour onset and growth in PyMT transgenic mice, despite an increase in the HDLc level. In contrast, D-4F treatment significantly increased tumour latency and inhibited the development of tumours. The effects of D-4F on tumour development were independent of 27-hydroxycholesterol. However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice and prevented oxLDL-mediated proliferative response in human breast adenocarcinoma MCF-7 cells. In conclusion, our study shows that D-4F, but not apoA-I-containing HDL, hinders tumour growth in mice with inherited breast cancer in association with a higher protection against LDL oxidative modification |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/srep36387 |
It is part of: | Scientific Reports, 2016, vol. 6, p. 36387 |
URI: | http://hdl.handle.net/2445/118640 |
Related resource: | https://doi.org/10.1038/srep36387 |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia) Articles publicats en revistes (Bioquímica i Biomedicina Molecular) Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
665488.pdf | 885.34 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License